Latest News

Kara Keilman, PharmD, senior medical science liaison at Lundbeck
Post Hoc Analysis Highlights Brexpiprazole’s Efficacy and Tolerability in Alzheimer Agitation

July 2nd 2025

As the first FDA-approved treatment for Alzheimer agitation, brexpiprazole showcased effective symptom relief with a favorable safety profile.

Long-Term 4-Year Data Highlights Sustained Effects of Deramiocel in DMD Cardiomyopathy
Long-Term 4-Year Data Highlights Sustained Effects of Deramiocel in DMD Cardiomyopathy

July 2nd 2025

NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease
NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease

July 2nd 2025

IJMSC Insights
IJMSC Insights: Francois Bethoux on 10 Years With IJMSC

July 1st 2025

Biogen's Salanersen Shows Promising Phase 1 Data in Spinal Muscular Atrophy
Biogen's Salanersen Shows Promising Phase 1 Data in Spinal Muscular Atrophy

July 1st 2025

Coverage of SLEEP 2025

Get direct access to interviews with experts, straight from the conference floor in Seattle, as well as the latest data and clinical news updates.

SLEEP 2025

Conference Coverage

View All
Kara Keilman, PharmD, senior medical science liaison at Lundbeck
Post Hoc Analysis Highlights Brexpiprazole’s Efficacy and Tolerability in Alzheimer Agitation

July 2nd 2025

Validating a Wearable-Based Classifier to Detect iRBD: Emmanuel During, MD
Validating a Wearable-Based Classifier to Detect iRBD: Emmanuel During, MD

July 2nd 2025

Targeting Sleep and the Glymphatic Pathway to Improve Stroke Rehabilitation Outcomes: Joyce Lee-Iannotti, MD, FAAN, FAASM
Targeting Sleep and the Glymphatic Pathway to Improve Stroke Rehabilitation Outcomes: Joyce Lee-Iannotti, MD, FAAN, FAASM

July 2nd 2025

NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease
NeuroVoices: Cheryl Kyinn, PA-C, on Personalizing On-Demand Therapies for OFF Episodes in Parkinson Disease

July 2nd 2025

Video Series
Video Interviews
Podcasts

Most Recent

© 2025 MJH Life Sciences

All rights reserved.